Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
pirfenidone axunio (previously pirfenidone aet)
axunio pharma gmbh - pirfenidone - fibrożi pulmonari idjopatika - immunosoppressanti - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
pirfenidone viatris
viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosoppressanti - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
esbriet
roche registration gmbh - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosoppressanti - esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
ofev
boehringer ingelheim international gmbh - nintedanib - fibrożi pulmonari idjopatika - aġenti antineoplastiċi - ofev huwa indikat fl-adulti għat-trattament tal-fibrożi pulmonari idjopatika (ipf).
Unjoni Ewropea -
Malti -
EMA (European Medicines Agency)
litfulo
pfizer europe ma eeig - ritlecitinib tosilate - alopecia areata - immunosoppressanti - litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.